Email not displaying properly? View email in your browser
Advertise | Archives
Starpharma signs drug delivery license with AstraZeneca

Pierre Fabre Pharmaceuticals and Addex Therapeutics sign early-stage agreement...

India's Cipla to acquire US-based InvaGen, Exelan Pharma for $550 mln

Recipharm in discussions with Alcon regarding long-term...

Sep 8th - Sep 11th
Rheumatology & Aging Conference 2015

Sep 15th - Sep 16th
Bioanalytical & Formulation Congress

Sep 29th - Oct 1st
Global Drug Formulations Summit 2015

Mayne Pharma invests $65 million to expand manufacturing facility in Greenville, North Carolina

Mayne Pharma Group Limited announced a US$65 million expansion of its operations in Greenville, NC, USA to support projected growth of US Products and Metrics Contract Services.The investment will fund a new...

Read More»»

Press Releases    
Yabao Pharmaceuticals and University of South Australia Announce New Joint Drug Discovery Laboratory

One of China’s leading pharmaceutical companies, Yabao Pharmaceutical Co, Inc. (Shanghai Stock Exchange 600351) and South Australia’s largest university, the University of South Australia, today announced an important new collaboration to develop new treatments for cancer.Under the terms of the agreement, the University of South Australia will identify drug candidates in a co-funded laboratory led by the University’s Professor Shudong Wang...

Featured Products    
The company specializes in manufacture and market a wide range of branded generic medicines covering almost all...
Throat Sprays
Throat Sprays are manufactured with innovative bag-on-valve packaging to soothe and prevent sore throat symptoms...
Advanced isolator technology
Increased product safety by reducing the risk of contamination with no direct contact between operators and product...
Advertise With Us | Company Registration | Subscribe| Unsubscribe – a product of Ochre Media Pvt. Ltd.
Ochre Media Pvt Ltd. Media Resource Centre, 2nd Floor, Oxford Plaza, Secunderabad - 500 003, Telangana, India
Tel: +91 40 4961 4567 I Fax: +91 40 4961 4555